EPISODE · Jan 25, 2017 · 1H
Dr. Aviva Romm, MD: Adrenals, Adaptogens and Thyroid Connection
from The Evan Brand Show · host Evan Brand, BCHN, FNTP
15-minute free consultation with Evan: evanbrand.com/free. Dr. Aviva Romm, MD is the mother of four grown children, a Yale-trained physician specializing in integrative medicine for women and children, a midwife, an herbalist, an award-winning author, and the creator/owner of WomanWise, online courses dedicated to the vitality and optimal health for women and children. An internationally respected expert in botanical and integrative medicine for women and children, she has spent nearly 30 years as a healthcare practitioner and advocate for the health and environmental concerns of women and kids. Today We Discuss Aviva's personal use of adaptogens during writing a book. How specific adaptogens can be used for various symptoms. Why an ''all in one'' adaptogen blend might not be the best choice. The Herb Pharm formulas and how the development took place.
What this episode covers
15-minute free consultation with Evan: evanbrand.com/free. Dr. Aviva Romm, MD is the mother of four grown children, a Yale-trained physician specializing in integrative medicine for women and children, a midwife, an herbalist, an award-winning author, and the creator/owner of WomanWise, online courses dedicated to the vitality and optimal health for women and children. An internationally respected expert in botanical and integrative medicine for women and children, she has spent nearly 30 years as a healthcare practitioner and advocate for the health and environmental concerns of women and kids. Today We Discuss Aviva's personal use of adaptogens during writing a book. How specific adaptogens can be used for various symptoms. Why an ''all in one'' adaptogen blend might not be the best choice. The Herb Pharm formulas and how the development took place.
NOW PLAYING
Dr. Aviva Romm, MD: Adrenals, Adaptogens and Thyroid Connection
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m